<DOC>
	<DOC>NCT00746135</DOC>
	<brief_summary>It's the aim of this study to investigate the impact of Right Ventricular (RV) lead position (RV-apex, His bundle area, RV-apex+His bundle area) in combination with individually optimized Left Ventricular (LV) lead placement and CRT timing on the outcome of cardiac resynchronization therapy (CRT).</brief_summary>
	<brief_title>TRI-V Heart Failure (HF) Implanted Cardioverter Defibrillator (ICD) Study</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Patient with indication for CRTD: NYHA IIIIV congestive heart failure, in spite of optimal medical treatment for their congestive heart failure LVEDD &gt; 55 mm or &gt; 30 mm/mÂ² BSA EF &lt; 35% Sinus rhythm and one of the following criteria: QRS &gt;= 120 ms and PQ &gt;= 200ms or 2nd / 3rd degree AV block Written informed consent pacemaker indication (without ICD indication) tricuspidal valve and/or aortic valve replacement Indication for revascularization. less than 3 month after heart surgery or myocardial infarction hypertrophic obstructive cardiomyopathy intravenous catecholamine treatment uncorrected thyroid function severe kidney disorder (creatinin &gt;2,5mg%) no written patient consent insufficient patient compliance participating in another study life expectancy &lt; 1 year due to other severe disease age &lt; 18 years no contraception (young women) or pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Heart failure (NYHA class III and IV)</keyword>
	<keyword>Ventricular Dyssynchrony</keyword>
</DOC>